MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 94 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $96,000 | -38.9% | 37,719 | -48.2% | 0.14% | +1700.0% |
| Q4 2019 | $157,000 | +23.6% | 72,885 | -11.3% | 0.01% | +33.3% |
| Q3 2019 | $127,000 | +8.5% | 82,170 | +192.4% | 0.01% | -14.3% |
| Q2 2019 | $117,000 | -45.6% | 28,103 | -45.4% | 0.01% | -46.2% |
| Q1 2019 | $215,000 | +211.6% | 51,453 | +114.4% | 0.01% | +225.0% |
| Q4 2018 | $69,000 | -58.7% | 24,001 | -45.2% | 0.00% | -42.9% |
| Q1 2018 | $167,000 | -83.9% | 43,828 | -65.5% | 0.01% | -84.8% |
| Q4 2017 | $1,035,000 | +1468.2% | 126,952 | +160.9% | 0.05% | +1433.3% |
| Q2 2017 | $66,000 | +4.8% | 48,658 | +36.3% | 0.00% | 0.0% |
| Q1 2017 | $63,000 | +293.8% | 35,701 | +112.1% | 0.00% | +200.0% |
| Q4 2016 | $16,000 | -77.5% | 16,830 | -57.0% | 0.00% | -95.7% |
| Q3 2016 | $71,000 | -62.6% | 39,100 | +56.6% | 0.02% | +155.6% |
| Q4 2015 | $190,000 | +12.4% | 24,969 | +22.9% | 0.01% | +50.0% |
| Q3 2015 | $169,000 | -12.0% | 20,323 | +22.5% | 0.01% | 0.0% |
| Q2 2015 | $192,000 | – | 16,595 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
| Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
| New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
| 683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
| Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
| Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
| THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
| Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
| Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
| GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |